{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T12:15:28Z","timestamp":1786709728327,"version":"build-2736575974"},"reference-count":29,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J NeuroIntervent Surg"],"accepted":{"date-parts":[[2022,11,7]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Percutaneous sclerotherapy is an effective treatment for lymphatic malformations (LM) of the head and neck in adults. The purpose of this study was to examine the indications and efficacy of sclerotherapy for head\/neck LM in the neonate and infant population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We retrospectively reviewed patients treated with percutaneous sclerotherapy for LM of the head\/neck at age \u226412 months at a single vascular anomalies clinic. The clinical, anatomic, and technical aspects of each treatment, complications, and post-treatment clinical and imaging outcomes were analyzed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>22 patients underwent 36 treatments during the first year of life. Median age at first treatment was 6.2 months (range 2\u2013320\u2009days). Severe airway compromise was the most frequent indication for treatment (31.8%). Sclerosants included doxycycline (80.5%), sodium tetradecyl sulfate (55.5%), bleomycin (11.1%) and ethanol (2.8%). There were no immediate procedure-related complications; sclerosant-related laboratory complications included transient metabolic acidosis (8.3%) and hemolytic anemia (5.5%). Median follow-up was 3.7 years (IQR 0.6\u20134.8). 47.6% of patients showed &gt;75% lesion size reduction and 19.0% showed minimal response (&lt;25% improvement). At last follow-up, 71.4% of children were developmentally normal and asymptomatic, 23.8% had recurring symptoms, and 4.8% required permanent tracheostomy. Patients with ongoing symptoms or limited response to percutaneous sclerotherapy (33.3%) were treated with long-term sirolimus.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Percutaneous sclerotherapy is a safe and effective treatment for symptomatic LM of the head and neck in neonates and infants. Treatment strategy and management of recurrent symptoms requires consensus from an experienced, multidisciplinary team.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jnis-2022-019516","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T13:20:20Z","timestamp":1669123220000},"page":"1242-1246","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Percutaneous sclerotherapy for head and neck lymphatic malformations in neonates and infants \u226412 months of age"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1581-7702","authenticated-orcid":false,"given":"M Travis","family":"Caton","sequence":"first","affiliation":[{"name":"Neurosurgery, Mount Sinai Health System, New York, New York, USA"},{"name":"Neurointerventional Radiology, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhavi","family":"Duvvuri","sequence":"additional","affiliation":[{"name":"Neurointerventional Radiology, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9973-5792","authenticated-orcid":false,"given":"Amanda","family":"Baker","sequence":"additional","affiliation":[{"name":"Neurointerventional Radiology, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6855-5104","authenticated-orcid":false,"given":"Eric R","family":"Smith","sequence":"additional","affiliation":[{"name":"Neurointerventional Radiology, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2019-5461","authenticated-orcid":false,"given":"Kazim H","family":"Narsinh","sequence":"additional","affiliation":[{"name":"Neurointerventional Radiology, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8209-0534","authenticated-orcid":false,"given":"Matthew R","family":"Amans","sequence":"additional","affiliation":[{"name":"Neurointerventional Radiology, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5885-7259","authenticated-orcid":false,"given":"Steven W","family":"Hetts","sequence":"additional","affiliation":[{"name":"Neurointerventional Radiology, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall T","family":"Higashida","sequence":"additional","affiliation":[{"name":"Neurointerventional Radiology, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L","family":"Cooke","sequence":"additional","affiliation":[{"name":"Neurointerventional Radiology, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher F","family":"Dowd","sequence":"additional","affiliation":[{"name":"Neurointerventional Radiology, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"2025092912083441000_15.12.1242.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2011.07.004"},{"key":"2025092912083441000_15.12.1242.2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jvsv.2019.09.007","article-title":"Sclerotherapy for lymphatic malformations of head and neck: systematic review and meta-analysis","volume":"8","author":"De Maria","year":"2020","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"2025092912083441000_15.12.1242.3","doi-asserted-by":"publisher","DOI":"10.1089\/lrb.2008.1004"},{"key":"2025092912083441000_15.12.1242.4","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jpedsurg.2021.12.056","article-title":"Sclerosing agents in the management of lymphatic malformations in children: a systematic review","volume":"57","author":"Fernandes","year":"2022","journal-title":"J Pediatr Surg"},{"key":"2025092912083441000_15.12.1242.5","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2015-012255"},{"key":"2025092912083441000_15.12.1242.6","article-title":"Prenatally diagnosed lymphatic malformations of the head and neck: clinical course at delivery, infancy, and beyond","volume":"3","author":"Wang","year":"2022","journal-title":"J Vasc Anom"},{"key":"2025092912083441000_15.12.1242.7","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1002\/lary.26468","article-title":"Sleep-disordered breathing in pediatric head and neck vascular malformations","volume":"127","author":"Durr","year":"2017","journal-title":"Laryngoscope"},{"key":"2025092912083441000_15.12.1242.8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.PRS.0000145633.99581.98","article-title":"Periorbital lymphatic malformation: clinical course and management in 42 patients","volume":"115","author":"Greene","year":"2005","journal-title":"Plast Reconstr Surg"},{"key":"2025092912083441000_15.12.1242.9","doi-asserted-by":"crossref","unstructured":"Blei F . Nomenclature of Vascular Anomalies: Evolution to the ISSVA 2018 Classification System. In: Trenor III CC , Adams DM , eds. Vascular Anomalies: A Guide for the Hematologist\/Oncologist. Springer International Publishing, 2020: 1\u20138.","DOI":"10.1007\/978-3-030-25624-1_1"},{"key":"2025092912083441000_15.12.1242.10","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1995.01890050065012"},{"key":"2025092912083441000_15.12.1242.11","doi-asserted-by":"publisher","DOI":"10.1136\/jnis-2022-019255"},{"key":"2025092912083441000_15.12.1242.12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1089\/lrb.2017.0062","article-title":"Treatment of lymphatic malformations with the mTOR inhibitor sirolimus: a systematic review","volume":"16","author":"Wiegand","year":"2018","journal-title":"Lymphat Res Biol"},{"key":"2025092912083441000_15.12.1242.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2003.11.011"},{"key":"2025092912083441000_15.12.1242.14","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jpedsurg.2020.09.017","article-title":"Management of cervicofacial lymphatic malformations requires a multidisciplinary approach","volume":"56","author":"Zobel","year":"2021","journal-title":"J Pediatr Surg"},{"key":"2025092912083441000_15.12.1242.15","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00431-020-03811-4","article-title":"Lymphatic malformations in children: treatment outcomes of sclerotherapy in a large cohort","volume":"180","author":"Bouwman","year":"2021","journal-title":"Eur J Pediatr"},{"key":"2025092912083441000_15.12.1242.16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ijporl.2015.03.024","article-title":"Efficacy of doxycycline and sodium tetradecyl sulfate sclerotherapy in pediatric head and neck lymphatic malformations","volume":"79","author":"Farnoosh","year":"2015","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"2025092912083441000_15.12.1242.17","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2016-012660"},{"key":"2025092912083441000_15.12.1242.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2007.10.009"},{"key":"2025092912083441000_15.12.1242.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2015.08.051"},{"key":"2025092912083441000_15.12.1242.20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.otc.2017.09.002","article-title":"New frontiers in our understanding of lymphatic malformations of the head and neck: natural history and basic research","volume":"51","author":"Perkins","year":"2018","journal-title":"Otolaryngol Clin North Am"},{"key":"2025092912083441000_15.12.1242.21","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-1642","article-title":"Methemoglobinemia in an infant after sclerotherapy with high-dose doxycycline","volume":"143","author":"Coughlin","year":"2019","journal-title":"Pediatrics"},{"key":"2025092912083441000_15.12.1242.22","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-006-0397-6"},{"key":"2025092912083441000_15.12.1242.23","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000002863"},{"key":"2025092912083441000_15.12.1242.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cps.2010.08.006"},{"key":"2025092912083441000_15.12.1242.25","doi-asserted-by":"publisher","DOI":"10.1001\/archoto.2011.199"},{"key":"2025092912083441000_15.12.1242.26","doi-asserted-by":"crossref","unstructured":"Shaheen MF , Tse JY , Sokol ES , et al . Genomic landscape of lymphatic malformations: a case series and response to the PI3K\u03b1 inhibitor alpelisib in an n-of-1 clinical trial. eLife;11.doi:10.7554\/eLife.74510","DOI":"10.7554\/eLife.74510"},{"key":"2025092912083441000_15.12.1242.27","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A7260"},{"key":"2025092912083441000_15.12.1242.28","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-017-3785-1"},{"key":"2025092912083441000_15.12.1242.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2008.02.016"}],"container-title":["Journal of NeuroInterventional Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnis-2022-019516","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:08:43Z","timestamp":1759172923000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnis.bmj.com\/lookup\/doi\/10.1136\/jnis-2022-019516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":29,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,11,16]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/jnis-2022-019516"],"URL":"https:\/\/doi.org\/10.1136\/jnis-2022-019516","relation":{},"ISSN":["1759-8478","1759-8486"],"issn-type":[{"value":"1759-8478","type":"print"},{"value":"1759-8486","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]}}}